RHYTHM PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Property, Plant and Equipment, Gross of $6.35 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-26
- 2025-12-31: Property, Plant and Equipment, Gross $6.35M.
- 2024-12-31: Property, Plant and Equipment, Gross $5.40M.
- 2023-12-31: Property, Plant and Equipment, Gross $5.40M.
- 2022-12-31: Property, Plant and Equipment, Gross $5.35M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2025-12-31 | $6.35M 10-K · filed 2026-02-26 |
| 2024-12-31 | $5.40M 10-K · filed 2026-02-26 |
| 2023-12-31 | $5.40M 10-K · filed 2025-02-28 |
| 2022-12-31 | $5.35M 10-K · filed 2024-02-29 |
| 2021-12-31 | $5.07M 10-K · filed 2023-03-01 |
| 2020-12-31 | $4.64M 10-K · filed 2022-03-01 |
| 2019-12-31 | $4.42M 10-K · filed 2021-03-01 |
| 2018-12-31 | $1.93M 10-K · filed 2020-03-02 |
| 2017-12-31 | $1.21M 10-K · filed 2019-03-08 |
| 2016-12-31 | $1.07M 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |